Sepp-Lorenzino Laura (CIK 0001777421)

Latest company ownership

NTLA - Intellia Therapeutics, Inc.

Role: EVP, Chief Scientific Officer

Shares held

77,388

Last filed at

Jan 7, 2025

Confidence Score

49.9

2025Q4

Confidence Score History

2021Q3 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Jan 3, 2025	Jan 7, 2025	Intellia Therapeutics, Inc.	EVP, Chief Scientific Officer	Sell	42.5	-8,966	-10.38%	✗	$109.2K
Jan 8, 2024	Jan 10, 2024	Intellia Therapeutics, Inc.	EVP, Chief Scientific Officer	Sell	37.5	-2,275	-4.92%	✓	$65.7K
Jan 3, 2024	Jan 5, 2024	Intellia Therapeutics, Inc.	EVP, Chief Scientific Officer	Sell	42.5	-5,532	-10.69%	✗	$163K
Jan 4, 2023	Jan 6, 2023	Intellia Therapeutics, Inc.	EVP, Chief Scientific Officer	Sell	15.0	-4,838	-21.53%	✓	$183K
Jan 1, 2022	Mar 3, 2022	Intellia Therapeutics, Inc.	EVP, Chief Scientific Officer	Sell	95.0	+12,668	212.44%	✗	$128.9K
Aug 30, 2021	Sep 1, 2021	Intellia Therapeutics, Inc.	EVP, Chief Scientific Officer	Sell	2.5	-97,000	-97.59%	✓	$15M
Aug 4, 2021	Aug 6, 2021	Intellia Therapeutics, Inc.	EVP, Chief Scientific Officer	Sell	5.0	-26,000	-91.58%	✓	$3.6M